Ibritumomab Intravenous and Migranal
Determining the interaction of Ibritumomab Intravenous and Migranal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: dihydroergotamine
Brand name: Migranal, DHE. 45
Synonyms: Migranal (nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Migranal nasal
- Ibritumomab Intravenous-MigraTen
- Ibritumomab Intravenous-Milantex
- Ibritumomab Intravenous-Mili
- Ibritumomab Intravenous-Mili Tablets
- Ibritumomab Intravenous-Milk of Magnesia
- Migranal-Ibritumomab Tiuxetan
- Migranal-Ibrutinib
- Migranal-Ibrutinib Capsules
- Migranal-Ibrutinib Tablets
- Migranal-Ibu
- Migranal-IBU Tablets